Tesla: Q1 Consensus Estimates

Tesla (NASDAQ: TSLA) will be reporting their first quarter financial results on April 26th after market close. Analysts have a consensus $650.81 12-month price target on the company, via a total of 38 analysts, with nine analysts having strong buy ratings. Six analysts meanwhile have buy ratings, 12 have hold ratings, seven analysts have a sell rating and four have strong sells on the company. The street high comes from Piper Sandler with a $1,200 price target, and the lowest target sits at $67 from GLJ Research.

21 analysts have revenue estimates for the first quarter. The mean revenue estimate between all 21 analysts is $10.62 billion; this number has been revised upwards from $10.3 billion at the start of the year. The highest revenue estimate is $12.34 billion, while the lowest is $8.2 billion.

Onto EBITDA estimates, there are currently only 8 analysts who have first-quarter EBITDA estimates. The mean is currently $1.8 billion, with this number having been revised down from $2 billion at the start of the year. The street high estimate currently sits at $2 billion in EBITDA and the lowest is $1.2 billion.

Analysts estimate that quarterly earnings per share will come in at $0.85, with this number being slightly revised down from $0.91 at the start of the year. Street high is $0.97 and the lowest estimate is $0.46 per share for the quarter.


Information for this briefing was found via Sedar and Refinitiv. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Why the Market May Be Misreading Iran | David Woo

Why US Fertilizer Supply Could Matter a Lot More Now | Pat Varas – Sage Potash

Roscan Gold: Mali Discount Hits Kandiole PEA

Recommended

Antimony Resources Expands New Discovery Following Trenching

Silver47 Kicks Off 7,000-Meter Drill Campaign at Nevada’s Hughes Project

Related News

Tesla Secures Lithium Supply From Core Lithium Via Binding Term Sheet

Tesla Inc (NASDAQ: TSLA) continues to secure its supply chain by going straight to raw...

Wednesday, March 2, 2022, 07:49:38 AM

Vireo Health: Canaccord Lowers Revenue Estimates, Reiterates Price Target

Vireo Health (CSE: VREO) reported its second-quarter financials’ on August 26th, indicating revenue for the...

Thursday, August 27, 2020, 05:30:27 PM

Dollarama: Analysts Anticipate $972.5 Million In Q1 2022 Revenue

Dollarama Inc (TSX: DOL) will be reporting its first quarter 2022 financial results on June...

Tuesday, June 8, 2021, 05:06:00 PM

Antibe Therapeutics: Canaccord Initiates Coverage, Issues $1.50 Price Target

Recently, Canaccord Genuity’s Tania Gonsalves initiated coverage on Antibe Therapeutics (TSXV: ATE), a biotechnology company...

Tuesday, August 18, 2020, 01:46:28 PM

Sundial: “Limited Financial Synergies Arising From the [Inner Spirit] Transaction”

Sundial Growers Inc. (NASDAQ: SNDL) has had a somewhat busy M&A news week this week,...

Sunday, May 9, 2021, 04:41:00 PM